This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Ajinomoto Co., Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovative Contributions of Makoto Ueno
Introduction
Makoto Ueno is a distinguished inventor based in Kanagawa, Japan. He has made significant strides in the field of medical technology, particularly in the evaluation of pancreatic cancer. His innovative approach combines biochemical analysis with advanced evaluation methods, showcasing his commitment to improving healthcare outcomes.
Latest Patents
Ueno holds a patent for a method and apparatus for evaluating pancreatic cancer. This patent includes a comprehensive system that utilizes amino acid concentration data obtained from blood samples. The method involves an obtaining step to gather data on amino acid concentrations and an evaluating step that calculates a value using a pre-established formula. This formula incorporates at least two explanatory variables based on the concentration values of specific amino acids, including Asn, His, Thr, and others. Ueno's patent represents a significant advancement in the early detection and evaluation of pancreatic cancer, potentially leading to better patient outcomes.
Career Highlights
Makoto Ueno is currently employed at Ajinomoto Co., Ltd., a company renowned for its contributions to food and biotechnology. His work at Ajinomoto has allowed him to collaborate with leading experts in the field, further enhancing his research and development capabilities. Ueno's dedication to innovation is evident in his focused efforts to address critical health issues through scientific inquiry.
Collaborations
Ueno has worked alongside notable colleagues, including Nobukazu Ono and Atsuko Shinhara. Their collaborative efforts have contributed to the advancement of research in the evaluation of pancreatic cancer, fostering a team environment that encourages innovation and discovery.
Conclusion
Makoto Ueno's contributions to the field of pancreatic cancer evaluation exemplify the impact of innovative thinking in healthcare. His patented methods and collaborative spirit continue to inspire advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile